AOTI.L
AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.
Industry
Medical - Specialties
IPO Date
2024-06-18
Stock Exchange
LSE
Ticker
AOTI.L
According to AOTI, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 16.75. This represents a change of -158.96% compared to the average of -28.41 of the last 4 quarters.
The mean historical PE Ratio of AOTI, Inc. over the last ten years is -565.21. The current 16.75 PE Ratio has changed -396.35% with respect to the historical average. Over the past ten years (40 quarters), AOTI.L's PE Ratio was at its highest in in the December 2024 quarter at 99.96. The PE Ratio was at its lowest in in the June 2023 quarter at -93.98.
Average
-565.21
Median
-53.30
Minimum
-2254.61
Maximum
100.39
Discovering the peaks and valleys of AOTI, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 274.00%
Maximum Annual PE Ratio = 100.39
Minimum Annual Increase = -122.40%
Minimum Annual PE Ratio = -2254.61
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -84.12 | 274.00% |
| 2023 | -22.49 | -122.40% |
| 2022 | 100.39 | -104.45% |
The current PE Ratio of AOTI, Inc. (AOTI.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.07
5-year avg
-565.21
10-year avg
-565.21
AOTI, Inc.’s PE Ratio is greater than Novacyt S.A. (-0.67), greater than Kooth plc (15.53), greater than Arecor Therapeutics plc (-3.45), greater than Renalytix Plc (-0.93), greater than Poolbeg Pharma PLC (-3.24), greater than SkinBioTherapeutics Plc (-13.10), greater than Creo Medical Limited (9.53), greater than hVIVO plc (3.19), greater than Hemogenyx Pharmaceuticals Plc (-5.79), greater than Inspiration Healthcare Group plc (-1.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.67 | N/A | |
| 15.53 | N/A | |
| -3.45 | N/A | |
| -0.93 | N/A | |
| -3.24 | N/A | |
| -13.10 | N/A | |
| 9.53 | N/A | |
| 3.19 | N/A | |
| -5.79 | N/A | |
| -1.15 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AOTI, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AOTI, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AOTI, Inc.'s PE Ratio?
How is the PE Ratio calculated for AOTI, Inc. (AOTI.L)?
What is the highest PE Ratio for AOTI, Inc. (AOTI.L)?
What is the 3-year average PE Ratio for AOTI, Inc. (AOTI.L)?
What is the 5-year average PE Ratio for AOTI, Inc. (AOTI.L)?
How does the current PE Ratio for AOTI, Inc. (AOTI.L) compare to its historical average?